Early response to OAB treatment predicts long-term therapeutic success
November 12th 2003Athens, Greece?Early response to treatment with an investigational anticholinergic agent for overactive bladder appears to be an accurate predictor of long-term therapeutic success, according to data recently presented at the AUA New York Section meeting.
Institute of Medicine report: Testosterone replacement trials should move forward
November 12th 2003Washington?Clinical studies on the use of testosterone replacement therapy in older men should move forward but only with a limited group of participants, according to a report released this week by an expert committee of the Institute of Medicine.
Can cystitis management be just a phone call away?
November 1st 2003Chicago-Large-scale telephone-based management of eligible women withpresumed cystitis is associated with low clinical recurrence rates and avery low incidence of other gynecourologic diagnoses, according to a studyfrom a large California health maintenance organization.
New drug targets considered for erectile dysfunction
November 1st 2003Paris-Basic research in erectile dysfunction therapy is being hamperedby the attitude of some funding bodies that phosphodiesterase type-5 inhibitorsalone have solved all problems, according to a special committee convenedat the 2nd International Consultation on Erectile and Sexual Dysfunctionshere.
Topping current ED therapies will be a major challenge
November 1st 2003Now more than ever before, men suffering from erectile dysfunction havea high likelihood that their condition will be successfully managed. Withtwo efficacious, safe, and easily administered oral medications on the marketand a third coming soon, men with ED are far better off than they were just6 years ago.
HIFU yields 73% cancer-free rate at 6 months
November 1st 2003Chicago-Treating localized prostate cancer with high-intensityfocused ultrasound (HIFU) appears to be safe, efficacious, and well tolerated,according to data presented by several European research groups at the AUAannual meeting in Chicago.
Project will document burden of urologic disease in U.S.
November 1st 2003The NIDDK-funded 'Urologic Diseases in America' is a broad-based, $6.9million project that will quantify the economic and human burden of urologicdiseases on the American population. In this exclusive Urology Times interview,Mark S. Litwin, MD, MPH, the study's principal investigator, outlines thescope of the project, its goals and objectives, and its relevance to practicingurologists. Dr. Litwin is professor of urology and public health at theDavid Geffen School of Medicine at UCLA and the UCLA School of Public Health.He is also a researcher at UCLA's Jonsson Comprehensive Cancer Center. Theinterview was conducted by UT Editorial Consultant Richard D. Williams,MD, professor and chairman of the department of urology at the Universityof Iowa, Iowa City.
Employee theft: Steps you can take to keep it in check
November 1st 2003Employee theft is more common than most of us want to admit. Many ofus are trusting and assume that our employees are honest and caring andwould not ever consider taking something from the practice that doesn'tbelong to them. I think, for the most part, health care does attract honest,caring, and compassionate employees, but that doesn't relieve us from practicingpreventive financial controls and creating an environment that avoids theftand embezzlement.
Feds: Jury awards are to blame for insurance hikes
November 1st 2003Washington-Congress has been told by its chief investigative agency thatincreasing medical liability awards, indeed, are contributing to skyrocketingpremium costs for many physicians, but that fact is not having a widespreadimpact on patients' access to health care.
BPH management: New paradigms, new approaches
November 1st 2003The paradigm for the medical management of benign prostatic hyperplasia has undergone a significant change during the past decade. Guided by new research, the approval of novel pharmaceutical and minimally invasive therapies, and the economics of health care financing, physicians have altered their approach to patient care in distinct ways.
Resistance to common UTI drugs continues to grow
November 1st 2003Chicago-Resistance to drugs commonly used against uncomplicated urinary tract infections continues to grow, according to the results of a large North American study presented at the 43rd Interscience Conference on Antimicrobials and Chemotherapy.
New formulas may be better for determining radiation therapy failure
October 30th 2003Salt Lake City--Prostate cancer researchers say they have developed methods to predict treatment failure in men undergoing radiation therapy that is more precise and specific than current American Society for Therapeutic Radiology and Oncology guidelines.
High-dose radiation for PCa effective at 10 years, has few side effects
October 30th 2003Salt Lake City--New research shows that men with clinically localized prostate cancer who are treated to high dose levels with three-dimensional conformal radiation therapy achieve long-term PSA relapse-free survival with minimal side effects.
Dr. See appointed chair of new Medical College of Wisconsin department
October 9th 2003The Board of Trustees of the Medical College of Wisconsin, Milwaukee,has approved the conversion of its division of urology to departmental status.William A. See, MD, has been appointed chairman of the new department.
Telephone management called safe for treating cystitis
October 9th 2003Large-scale telephone-based management of eligible women with presumedcystitis is associated with low clinical recurrence rates and a very lowincidence of other gynecourologic diagnoses, according to a study by a largeHMO in California.
New technology can detect low-level PSA following prostatectomy
October 9th 2003Scientists at Northwestern University have developed an ultra-sensitivetechnology based on gold nanoparticles and DNA that can detect PSA whenpresent at extremely low levels in the blood sample. The new protein-detectionmethod could be used to monitor prostate cancer patients following surgery,according to the researchers, whose findings are published in the Sept.26 issue of the journal Science (2003; 301:1884-6).
Prostate Ca screening interval of 4 years misses few cancers
October 9th 2003A 4-year screening interval was found adequate for detecting most cancersin a large European randomized trial of prostate cancer screening, accordingto a study in the Oct. 1 issue of the Journal of the National CancerInstitute (2003; 95:1462-6).